This study represents the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein, offering the potential for direct blood glucose measurement without the limitations ...

Glucotrack has successfully completed a first-in-human study with its continuous glucose monitor (CGM) that directly measures ...

Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization ...

Introduction to Digital Health and WellnessThe digital health and wellness industry is experiencing significant growth as healthcare increasingly incorporates technology to improve the quality, ...

A DGIST research team, led by Professor Kyung-In Jang, has developed a smart patch capable of real-time biometric signal ...

The COVID-19 pandemic undoubtedly changed how clinical trials were conducted Guidance had to be quickly issued to protect patients and maintain good clinical practice standards Remote monitoring becam ...

RUTHERFORD, NJ - Glucotrack, Inc. (NASDAQ:GCTK), a developer of medical technologies for diabetes care, has announced the pricing of its public offering at $1.15 per share, aiming to raise ...

Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...

New research links nighttime light exposure to increased diabetes risk. Find out how your bedroom environment might be affecting your health ...

First, know that chatbots – ChatGPT, Claude, Perplexity, Copilot, Gemini, and others – are an immensely powerful type of AI ...

Nearly 80% of urgent calls for help go unanswered when older adults are alone, underscoring the urgent need for ...